title: Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools.
abstract: Aberrant DNA methylation patterns have been identified in a variety of human diseases, particularly cancer. Pyrosequencing has evolved in recent years as a sensitive and accurate method for the analysis and quantification of the degree of DNA methylation in specific target regions. However, the number of candidate genes that can be analyzed in clinical specimens is often restricted by the limited amount of sample available. Here, we present a novel screening approach that enables the rapid identification of differentially methylated regions such as promoters by pyrosequencing of etiologically homogeneous sample pools after bisulfite treatment. We exemplify its use by the analysis of five genes (CDKN2A, GSTP1, MLH1, IGF2, and CTNNB1) involved in the pathogenesis of human hepatocellular carcinoma using pools stratified for different parameters of clinical importance. Results were confirmed by the individual analysis of the samples. The screening identified all genes displaying differential methylation successfully, and no false positives occurred. Quantitative comparison of the pools and the samples in the pool analyzed individually showed a deviation of approximately 1.5%, making the method ideally suited for the identification of diagnostic markers based on DNA methylation while saving precious DNA material.
authors: Laboratory for Epigenetics, Centre National de Génotypage, Bâtiment G2, 2 rue Gaston Crémieux, CP 5721, 91057 Evry Cedex, France.
authors: Emelyne
authors: E
authors: Dejeux
authors: Virginie
authors: V
authors: Audard
authors: Catherine
authors: C
authors: Cavard
authors: Ivo Glynne
authors: IG
authors: Gut
authors: Benoit
authors: B
authors: Terris
authors: Jörg
authors: J
authors: Tost
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000235:genetics*; D018899:CpG Islands; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000235:genetics; D006801:Humans; D011401:Promoter Regions, Genetic / Q000235:genetics*; D018401:Sample Size; D017422:Sequence Analysis, DNA / Q000379:methods*
chemical_list: D004273:DNA, Neoplasm
references: Nat Genet. 2000 Feb;24(2):132-8
references: 10655057
references: Cancer Res. 2006 Jul 1;66(13):6546-52
references: 16818626
references: Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4465-70
references: 11904358
references: Clin Cancer Res. 2002 Apr;8(4):1087-92
references: 11948118
references: Biotechniques. 2002 May;32(5):1138-42
references: 12019787
references: Biotechniques. 2002 May;32(5):1144-6, 1148, 1150 passim
references: 12019788
references: Nat Rev Genet. 2002 Jun;3(6):415-28
references: 12042769
references: Hum Genet. 2002 May;110(5):395-401
references: 12073008
references: Electrophoresis. 2002 Dec;23(24):4072-9
references: 12481262
references: Br J Cancer. 2003 Feb 24;88(4):521-9
references: 12592365
references: Nat Rev Cancer. 2003 Apr;3(4):253-66
references: 12671664
references: Biotechniques. 2003 Jul;35(1):146-50
references: 12866414
references: Biotechniques. 2003 Jul;35(1):152-6
references: 12866415
references: J Pathol. 2003 Nov;201(3):473-9
references: 14595760
references: World J Gastroenterol. 2004 Sep 15;10(18):2740-3
references: 15309731
references: Anal Biochem. 2004 Oct 1;333(1):119-27
references: 15351288
references: Hepatology. 1996 Aug;24(2):289-93
references: 8690394
references: Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8847-51
references: 9671767
references: Science. 1998 Jul 17;281(5375):363, 365
references: 9705713
references: Nat Med. 1998 Nov;4(11):1276-80
references: 9809551
references: Oncogene. 1999 Jan 21;18(3):789-95
references: 9989830
references: J Mol Diagn. 2005 Feb;7(1):105-10
references: 15681481
references: Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R65-76
references: 15809275
references: Mutat Res. 2005 Jun 3;573(1-2):96-102
references: 15829240
references: J Mol Diagn. 2005 May;7(2):198-205
references: 15858143
references: Clin Cancer Res. 2005 May 15;11(10):3654-60
references: 15897561
references: World J Gastroenterol. 2005 Jul 28;11(28):4404-8
references: 16038042
references: J Mol Diagn. 2005 Aug;7(3):413-21
references: 16049314
references: Nat Rev Genet. 2005 Aug;6(8):597-610
references: 16136652
references: Expert Rev Mol Diagn. 2005 Nov;5(6):947-53
references: 16255635
references: Nat Rev Drug Discov. 2006 Jan;5(1):37-50
references: 16485345
references: J Mol Diagn. 2006 May;8(2):152-6
references: 16645200
references: J Mol Diagn. 2006 May;8(2):209-17
references: 16645207
references: J Mol Med (Berl). 2006 May;84(5):365-77
references: 16416310
references: Nucleic Acids Res. 2006;34(8):e59
references: 16670426
references: Cancer Res. 2006 May 15;66(10):5495-503
references: 16707479
references: Clin Chem. 2006 Jun;52(6):1005-13
references: 16574761
references: J Mol Diagn. 2006 Sep;8(4):444-8
references: 16931584
references: J Pathol. 2007 Mar;211(4):410-9
references: 17278115
references: Biotechniques. 2006 Jun;40(6):721-2, 724, 726
references: 16774114
references: Hum Mol Genet. 2006 Jul 1;15(13):2038-44
references: 16698880
references: Mol Carcinog. 2006 Jul;45(7):530-6
references: 16649250
references: Semin Cancer Biol. 2000 Jun;10(3):185-200
references: 10936068